Back to Search
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Palo Alto, California, 94305
Omaha, Nebraska, 68130
San Diego, California, 92093
Los Angeles, California, 90095
Los Angeles, California, 90033
Omaha, Nebraska, 68130
San Diego, California, 92093
Los Angeles, California, 90095
Los Angeles, California, 90033
Search ended 05/31/2024
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of KIN-2787 in adults with BRAF/NRAS-mutated advanced or metastatic solid tumors.
Eligibility
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, learn about Clinical
| Ages Eligible for Study | Min Age: 18 years - Max Age: N/A |
| Sexes Eligible for Study | All |
| Accepts Healthy Volunteers | No |
Visit ClinicalTrials.Gov for more information
Support nonprofit organizations through participating in clinical trials at no cost to you
You may also be interested in
Tuscaloosa, Alabama and more
Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury
Neurobehavioral Disinhibition Read more
Grand Junction, CO and more
A Study of mRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age
Cytomegalovirus Read more
Palo Alto, California and more